Table 2.
TG precursor | control | HTG | HTG + T2D | |||
---|---|---|---|---|---|---|
TG (mg/dL) | % reduction | TG (mg/dL) | % reduction | TG (mg/dL) | % reduction | |
All sources | 62 | - | 179 | - | 191 | - |
Eliminate: | ||||||
NEFA | 3 | -95% | 32 | -82% | 43 | -78% |
de novo lipogenesis | 60 | -3% | 153 | -15% | 171 | -10% |
Diet | 60 | -3% | 173 | -3% | 167 | -13% |
Vedala et al[46] studied the relative contribution of various FA sources to VLDL-TG. They report the plasma TG and the absolute contribution of each FA source to VLDL-TG synthesis, which was measured during tracer kinetics study and reported in g/day. We used the reported parameters to estimate the reduction in serum TG that would correspond to the elimination of each FA source, assuming no change in TG clearance.